BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 10, 2025
Home » Authors » Omar Ford

Articles by Omar Ford

Cleveland Clinic Medical Innovation Summit: P4 Medicine concept divides healthcare into both wellness, disease segments

Oct. 29, 2014
By Omar Ford
CLEVELAND — If you were to ask Leroy Hood about what he thinks will happen to the current healthcare model in the future, more than likely the Institute for Systems Biology (Seattle) founder would say that patients will start to take more interest and ownership in their health and well being. Hood was the keynote speaker on Tuesday during the Cleveland Clinic's Medical Innovation Summit and discussed the role of medicine in the future, thusly impacted by the P4 Medicine model.
Read More

Cleveland Clinic Medical Innovation Summit: Myriad's Capone sees greater role for companion diagnostics

Oct. 29, 2014
By Omar Ford

Cleveland Clinic Medical Innovation Summit:: Innovation is more than a buzzword, it's lifeblood of healthcare industry

Oct. 28, 2014
By Omar Ford
Cleveland — Just what is the State of Innovation in Healthcare? Five panelists and a moderator discussed the topic during a session at Cleveland Clinic's Medical Innovation Summit on Monday afternoon. While many have prognositcated that when it comes to med-tech innovation, there is a great deal of doom and gloom on the horizon, that isn't necessarily the case and that prognostication could have dire implications for healthcare.
Read More

Rock Health founder discusses opportunities in mobile health

Oct. 28, 2014
By Omar Ford

Cleveland Clinic Innovation Summit: Cleveland Clinic gets 'personal' with cancer therapy during innovation summit

Oct. 27, 2014
By Omar Ford
CLEVELAND — Personalized medicine – particularly as it pertains to cancer treatments – is the focus of this year's Cleveland Clinic Medical Innovation Summit. The 12th annual summit titled, "This time It's Personal," will bring in more than 1,500 attendees to the Cleveland Convention Center.
Read More

MDD's Dignostics Extra

Oct. 24, 2014
By Omar Ford

NewCo on the Go: NuVascular forms in effort to get artificial blood vessels to market

Oct. 24, 2014
By Omar Ford

Say it with me... Google Glass is the next big thing in healthcare

Oct. 23, 2014
By Omar Ford
Physicians and surgeons are going to flock to Google Glass. That's my bold prediction and I'm sticking to it. I mean come on, just look at the impact the i-Pad has had on healthcare facilities across the country - sorry world. Now one of the main reasons Google Glass is going to make a strong impact, is because of it gives surgeons access to patient information and apps, at the benefit of freeing up the physician's hands. It's a common sense selling point, that I missed when I demo-ed the technology about a year ago. But what brought this fact...
Read More

Beta-O2 treats first patient in Bio-Artificial pancreas trial

Oct. 23, 2014
By Omar Ford

Veracyte developing new test to remove ambiguity from ILD screening

Oct. 21, 2014
By Omar Ford
Previous 1 2 … 73 74 75 76 77 78 79 80 81 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 9, 2025.
  • US flag, stock market chart, White House

    100 days of uncertainty

    BioWorld
    The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • NME Digest: Q1 2025

    BioWorld
    A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing